My wife relapsed while taking Ibrutinb after three years. She went into a clinical trial for ABT199 (Venetaclax). After 7 months she is relapsing again. She has CLL-17p. A CAR-T trial at Fred Huchinson Cancer Center in Seattle was recommended to her by her doctor at Stanford. Anybody have any thoughts?
You must log in to use this feature, please click here to login.